Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, et al.
Science Signaling (2020) Vol. 13, Iss. 625
Open Access | Times Cited: 315

Showing 26-50 of 315 citing articles:

The emerging role of GABA as a transport regulator and physiological signal
Bo Xu, Na Sai, Matthew Gilliham
PLANT PHYSIOLOGY (2021) Vol. 187, Iss. 4, pp. 2005-2016
Open Access | Times Cited: 62
Molecular insights into the biased signaling mechanism of the μ-opioid receptor
Xiaojing Cong, Damien Maurel, Hélène Déméné, et al.
Molecular Cell (2021) Vol. 81, Iss. 20, pp. 4165-4175.e6
Open Access | Times Cited: 60
Cytokine engineering for targeted cancer immunotherapy
Lucia Bonati, Li Tang
Current Opinion in Chemical Biology (2021) Vol. 62, pp. 43-52
Open Access | Times Cited: 57
Biased Agonism: Lessons from Studies of Opioid Receptor Agonists
Eamonn Kelly, Alexandra E. Conibear, Graeme Henderson
The Annual Review of Pharmacology and Toxicology (2022) Vol. 63, Iss. 1, pp. 491-515
Open Access | Times Cited: 48
Structure‐Based Evolution of G Protein‐Biased μ‐Opioid Receptor Agonists
Haoqing Wang, Florian Hetzer, Weijiao Huang, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 26
Open Access | Times Cited: 45
Ketamine; history and role in anesthetic pharmacology
Kazuyoshi Hirota, David G. Lambert
Neuropharmacology (2022) Vol. 216, pp. 109171-109171
Open Access | Times Cited: 44
Recent progress in assays for GPCR drug discovery
Shimeng Guo, Tingting Zhao, Ying Yun, et al.
AJP Cell Physiology (2022) Vol. 323, Iss. 2, pp. C583-C594
Closed Access | Times Cited: 42
The molecular pharmacology of glucagon agonists in diabetes and obesity
Aaron Novikoff, Timo D. Müller
Peptides (2023) Vol. 165, pp. 171003-171003
Open Access | Times Cited: 41
Heroin and its metabolites: relevance to heroin use disorder
Michele Stanislaw Milella, Ginevra D’Ottavio, Silvana De Pirro, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 28
A community Biased Signaling Atlas
Jimmy Caroli, Alibek Mamyrbekov, Kasper Harpsøe, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 5, pp. 531-535
Closed Access | Times Cited: 25
Mu-opioid receptor selective superagonists produce prolonged respiratory depression
Nicholas J. Malcolm, Barbara Palković, Daniel J. Sprague, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107121-107121
Open Access | Times Cited: 23
GPCR signaling bias: an emerging framework for opioid drug development
Ryoji Kise, Asuka Inoue
The Journal of Biochemistry (2024) Vol. 175, Iss. 4, pp. 367-376
Open Access | Times Cited: 10
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein Signaling
Meng-Hua M. Tsai, Li Chen, Michael H. Baumann, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 4, pp. 854-867
Closed Access | Times Cited: 9
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB1 receptor
Beth Ryalls, Monica Patel, Eric Sparkes, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116052-116052
Open Access | Times Cited: 9
Pain Signaling by GPCRs and RTKs
B. Schmidt, Francesco De Logu, Romina Nassini, et al.
Trends in Pharmacological Sciences (2025)
Closed Access | Times Cited: 1
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
Joaquim Azevedo Neto, Anna Costanzini, Roberto De Giorgio, et al.
Molecules (2020) Vol. 25, Iss. 17, pp. 3870-3870
Open Access | Times Cited: 67
Intrinsic Efficacy of Opioid Ligands and Its Importance for Apparent Bias, Operational Analysis, and Therapeutic Window
Alexander Gillis, Varun Sreenivasan, MacDonald J. Christie
Molecular Pharmacology (2020) Vol. 98, Iss. 4, pp. 410-424
Open Access | Times Cited: 62
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site
Rajendra Uprety, Tao Che, Saheem A. Zaidi, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 53
The therapeutic potential of GLP‐1 receptor biased agonism
Ben Jones
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 492-510
Open Access | Times Cited: 53
Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice
He Li, Sarah W. Gooding, Elinor Lewis, et al.
Neuropsychopharmacology (2021) Vol. 46, Iss. 13, pp. 2241-2249
Open Access | Times Cited: 52
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F. DiBerto, Abdelfattah Faouzi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13873-13892
Open Access | Times Cited: 50
Strategies towards safer opioid analgesics—A review of old and upcoming targets
Balázs Varga, John M. Streicher, Susruta Majumdar
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 975-993
Open Access | Times Cited: 48
Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns
Adrián Ricarte, James A. R. Dalton, Jesús Giraldo
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 3, pp. 1251-1274
Open Access | Times Cited: 47
Structural Insights Accelerate the Discovery of Opioid Alternatives
Tao Che, Bryan L. Roth
Annual Review of Biochemistry (2021) Vol. 90, Iss. 1, pp. 739-761
Open Access | Times Cited: 43

Scroll to top